Advertisement
Singapore markets open in 5 hours 11 minutes
  • Straits Times Index

    3,322.62
    +14.72 (+0.45%)
     
  • S&P 500

    5,265.81
    -41.20 (-0.78%)
     
  • Dow

    39,056.24
    -614.80 (-1.55%)
     
  • Nasdaq

    16,723.67
    -77.87 (-0.46%)
     
  • Bitcoin USD

    67,307.53
    -2,369.52 (-3.40%)
     
  • CMC Crypto 200

    1,461.81
    -40.86 (-2.72%)
     
  • FTSE 100

    8,339.23
    -31.10 (-0.37%)
     
  • Gold

    2,335.20
    -57.70 (-2.41%)
     
  • Crude Oil

    76.83
    -0.74 (-0.95%)
     
  • 10-Yr Bond

    4.4750
    +0.0410 (+0.92%)
     
  • Nikkei

    39,103.22
    +486.12 (+1.26%)
     
  • Hang Seng

    18,868.71
    -326.89 (-1.70%)
     
  • FTSE Bursa Malaysia

    1,629.18
    +7.09 (+0.44%)
     
  • Jakarta Composite Index

    7,222.38
    +36.34 (+0.51%)
     
  • PSE Index

    6,659.99
    +52.77 (+0.80%)
     

A Struggling Pfizer Looks for Help From a Wall Streeter

A Struggling Pfizer Looks for Help From a Wall Streeter

As the big drugmaker tries to turn its fortunes around by focusing on oncology, it has turned to a Citi analyst who hasn’t recommended the stock in over a decade. But Andrew Baum has something Pfizer needs: oncology expertise.